Arcutis Biotherapeutics Inc share price logo

Arcutis Biotherapeutics Inc Share Price

NASDAQ: ARQT

Mid Cap

$24.86

+0.04

(+0.18%)

Live

as on

Arcutis Biotherapeutics Inc Stock Performance

as on March 11, 2026 at 4:12 am IST

  • Day's Low

    Day's High

    $24.55
    $25.53
    downward going graph

    1.25%

    Downside

    2.70%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $11.86
    $31.77
    downward going graph

    52.29%

    Downside

    27.80%

    Upside

    downward going graph

Arcutis Biotherapeutics Inc share price movements today

Previous Close
$24.82
Open
$25.06
Volume
444.8K
Day's Low - High
$24.55 - $25.53
52 Week Low - High
$11.86 - $31.77

Arcutis Biotherapeutics Inc Historical Returns

1 Month Return
-7.66 %
3 Month Return
-16.63 %
1 Year Return
+ 72.6 %
3 Year Return
+ 105.29 %
5 Year Return
-22.92 %

Arcutis Biotherapeutics Inc Stock Fundamentals & Key Indicators

Check Arcutis Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.0B

EPS (TTM)

0.3671

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.47

Industry PE ratio

-3.0981227436823104

PEG Ratio

0

EBITDA

-7.6M

Revenue (TTM)

376.1M

Profit Margin

-4.29%

Return On Equity TTM

-9.30%

Arcutis Biotherapeutics Inc Stock Valuation

Track how Arcutis Biotherapeutics Inc P/E has moved over time to understand its valuation trends.

Arcutis Biotherapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-182.85x)

December 31, 2025

Today (-6.47x)

March 10, 2026

Industry (-3.10x)

March 10, 2026

Highest (-0.69x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -6.47x

Arcutis Biotherapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Arcutis Biotherapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$3.0B-22.92%-6.47-4.29%
BUY$42.5B140.27%137.038.45%
BUY$116.0B115.07%29.8532.94%
NA$33.3BNA590.435.37%
BUY$80.3B67.03%18.3131.41%

Stock Returns calculator for Arcutis Biotherapeutics Inc Stock including INR - Dollar returns

The Arcutis Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Arcutis Biotherapeutics Inc investment value today

Current value as on today

₹1,78,071

Returns

₹78,071

(+78.07%)

Returns from Arcutis Biotherapeutics Inc Stock

₹72,879 (+72.88%)

Dollar Returns*

₹5,192 (+5.19%)

Analyst Recommendation on Arcutis Biotherapeutics Inc Stock

Based on 13 analysts

BUY

76.92%

Buy

23.08%

Hold

0.00%

Sell

Based on 13 analysts, 76.92% of analysts recommend a 'BUY' rating for Arcutis Biotherapeutics Inc. Average target price of $34.75

Arcutis Biotherapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Arcutis Biotherapeutics Inc.

What analysts predicted

28.46%UPSIDE

Target Price

$34.75

Current Price

$24.86

Analyzed by

13 Analysts

Target

$34.75

Arcutis Biotherapeutics Inc target price $34.75, a slight upside of 28.46% compared to current price of $24.86. According to 13 analysts rating.

Arcutis Biotherapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Arcutis Biotherapeutics Inc Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-18% versus previous 30 day period

Arcutis Biotherapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
38
13
49
30
44
71
65
81
99
129
Gross Profit
36
11
46
27
39
64
57
74
90
117
Operating Income
-36
-61
-31
-50
-39
-7
-24
-14
8
18
EBITDA
-33
-58
-27
-44
-33
-4
-18
-11
11
22
Interest Expense
7
7
7
7
6
5
2
3
3
3
Depreciation
0
0
0
0
1
0
3
0
0
0
Income Before Tax
-41
-66
-35
-52
-41
-10
-24
-15
7
17
Income Tax Expense
3
0
0
0
-
0
0
0
0
0
Net Income
-44
-66
-35
-52
-41
-10
-25
-15
7
17
Net Profit Margin
-117.47%
-490.05%
-71.38%
-169.59%
-92.81%
-15.12%
-38.06%
-19.49%
7.47%
13.43%

Arcutis Biotherapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
3
59
196
376
Gross Profit
-
-
0
0
0
2
54
177
339
Operating Income
-4
-19
-43
-136
-206
-301
-241
-128
-12
EBITDA
-4
-19
-41
-135
-206
-294
-227
-109
2
Interest Expense
-
-
-
-
0
15
29
27
12
Depreciation
-
-
0
0
0
0
1
2
4
Income Before Tax
-4
-19
-41
-135
-206
-311
-259
-139
-14
Income Tax Expense
-4
0
0
0
0
9
3
0
1
Net Income
-4
-19
-41
-135
-205
-311
-262
-140
-16
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-8449.76%
-439.79%
-71.25%
-4.29%

Arcutis Biotherapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-66
-35
-52
-41
-10
-25
-15
7
17
Operating Cash Flow
-56
-31
-45
-34
0
-30
0
-1
26
Investing Cash Flow
-62
-28
-62
84
34
11
17
-25
-34
Financing Cash Flow
99
161
1
0
-97
0
1
1
3
Change in Cash
-19
101
-105
50
-63
-18
19
-25
-4

Arcutis Biotherapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-19
-41
-135
-206
-311
-262
-140
-16
Operating Cash Flow
-14
-42
-113
-174
-257
-247
-112
-5
Investing Cash Flow
-11
-26
-181
-75
-87
180
28
-30
Financing Cash Flow
61
93
298
281
301
101
66
6
Change in Cash
35
23
3
31
-43
34
-17
-28

Global Institutional Holdings in Arcutis Biotherapeutics Inc

Funds
Holdings
D. E. Shaw & Co LP
2.16%
Geode Capital Management, LLC
2.1%
Point72 Asset Management, L.P.
1.24%
HHG PLC
1.93%
Franklin Resources Inc
1.86%

Arcutis Biotherapeutics Inc News & Key Events

  • img

    Today's Timeline - 17 December

    Wed, 10:30 PM

    -

    Arcutis Biotherapeutics reports strong performance of Zoryve, boosting sales through consistent label expansion.

    Thu, 04:28 AM

    -

    Insider sold shares worth $332,851, according to a recent SEC filing.

Insights on Arcutis Biotherapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ARQT stock has moved up by 5.2%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 65.84M → 129.50M (in $), with an average increase of 20.2% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ARQT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ARQT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -25.06M → 17.39M (in $), with an average increase of 143.2% per quarter

About Arcutis Biotherapeutics Inc

arcutis biotherapeutics, inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. its lead product candidate is arq-151, a topical cream formulation of roflumilast that is in phase iii clinical trials for the treatment of plaque psoriasis and atopic dermatitis. the company is also developing arq-154, a topical foam formulation of arq-151 for the treatment of seborrheic dermatitis and scalp psoriasis; arq-252, a selective topical small molecule inhibitor of janus kinase type 1 for hand eczema and other inflammatory dermatoses; and arq-255, a topical formulation of arq-252 designed to reach deeper into the skin to the postulated site of inflammation in alopecia areata. the company was formerly known as arcutis, inc. and changed its name to arcutis biotherapeutics, inc. in october 2019. arcutis biotherapeutics, inc. was founded in 2016 and is headquartered in westlake village, california.
OrganisationArcutis Biotherapeutics Inc
Headquarters3027 Townsgate Road, Westlake Village, CA, United States, 91361
IndustryHealth Technology
CEOMr. Todd Franklin Watanabe M.A.
E-voting on sharesClick here to vote

Key Management of Arcutis Biotherapeutics Inc

Name

Title

Mr. Todd Franklin Watanabe M.A.

President, CEO & Director

Dr. Bhaskar Chaudhuri Ph.D.

Co-Founder & Director Emeritus

Mr. Masaru Matsuda Esq., J.D.

Executive VP, Chief Legal Officer & Corporate Secretary

Mr. Larry Todd Edwards

Executive VP & Chief Commercial Officer

Ms. Latha Vairavan

Chief Financial Officer

Mr. Rajvir Madan

Chief Digital & Technology Officer

Dr. Patrick E. Burnett M.D., Ph.D.

Executive VP & Chief Medical Officer

Mr. Brian Schoelkopf

Head of Investor Relations

Mr. Steve Arias

Vice President of Compliance & Privacy

Ms. Amanda Sheldon

Head of Corporate Communications

FAQs

What is Arcutis Biotherapeutics Inc share price today?

Arcutis Biotherapeutics Inc share price today is $24.86 as on . Arcutis Biotherapeutics Inc share today touched a day high of $25.53 and a low of $24.55.

What is the 52 week high and 52 week low for Arcutis Biotherapeutics Inc share?

Arcutis Biotherapeutics Inc share touched a 52 week high of $31.77 on and a 52 week low of $11.86 on . Arcutis Biotherapeutics Inc stock price today i.e. is trending at $24.86,which is 21.75% down from its 52 week high and 109.61% up from its 52 week low.

What is Arcutis Biotherapeutics Inc's market capitalisation today?

Arcutis Biotherapeutics Inc market capitalisation is $0.00T as on .

How to invest in Arcutis Biotherapeutics Inc Stock (ARQT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Arcutis Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arcutis Biotherapeutics Inc Shares that will get you 0.0603 shares as per Arcutis Biotherapeutics Inc share price of $24.86 per share as on March 10, 2026 at 10:42 pm IST.

What is the minimum amount required to buy Arcutis Biotherapeutics Inc Stock (ARQT) from India?

Indian investors can start investing in Arcutis Biotherapeutics Inc (ARQT) shares with as little as ₹91.833 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹918.33 in Arcutis Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Arcutis Biotherapeutics Inc share’s latest price of $24.86 as on March 10, 2026 at 10:42 pm IST, you will get 0.4023 shares of Arcutis Biotherapeutics Inc. Learn more about fractional shares .

What are the returns that Arcutis Biotherapeutics Inc has given to Indian investors in the last 5 years?

Arcutis Biotherapeutics Inc stock has given -22.92% share price returns and 26.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?